Tobias Schimming

TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

Klaus Griewank, Rajmohan Murali, Joan Anton Puig‐Butillé et al. · JNCI Journal of the National Cancer Institute · 2014 · 258 citations · Full text

Medicine, Dermatology, Oncology +17

Conjunctival Melanomas Harbor <i>BRAF</i> and <i>NRAS</i> Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas

Klaus Griewank, Henrike Westekemper, Rajmohan Murali et al. · Clinical Cancer Research · 2013 · 223 citations

Medicine, Genetics, Oncology +17

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway

Rajmohan Murali, Raghu Chandramohan, Inga Möller et al. · Oncotarget · 2015 · 131 citations · Full text

Medicine, Genetics, Oncology +17

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma

Klaus Griewank, Rajmohan Murali, Bastian Schilling et al. · PLoS ONE · 2013 · 103 citations · Full text

Medicine, Genetics, Oncology +16

SF3B1 and BAP1 mutations in blue nevus-like melanoma

Klaus Griewank, Hansgeorg Müller, Louise Jackett et al. · Modern Pathology · 2017 · 103 citations · Full text

Medicine, Molecular Genetics, Oncology +14